A portable device designed for phototherapy during hospitalisation, outpatient care and during the transition from clinical care to everyday life in the home environment. Thanks to the specific spectral composition of the integrated LEDs, it provides uniquely high therapeutic efficiency and visual comfort thanks to its large emitting area and optimised brightness component. Its effectiveness has been proven by the National Institute of Mental Health of the Czech Republic.
Products
Spectrasol phototherapy case
Variants and prices
Basic technical info
Mounting type
standalone, table-top versions
Light source type
therapeutic, photobiomodulating, 5000 K , CRI 80, mDER 0.934 (D65)
Light distribution type
large-area direct
Recommended use
specialist psychiatry sector, sleep and chronobiology, spa and special therapy
Colour version
silver
Notes
This phototherapy device is only intended for specialised physicians and health professionals who will apply phototherapy as part of treating their patients.
- 5-year warranty
- highly effective patented therapeutic LED light source
- available for outpatient and home application for treatment and prevention
- proven effectiveness for a range of mental disorders
- detailed NIDA certified methodology can be used for application
- circadian effectiveness comparable to the sun
- high representation of cyan wavelengths in the 460-520 nm region ensuring maximum melanopic stimulation
- full-area flat and pleasant distribution of therapeutic light
- high light intensity while maintaining visual comfort
The dimensions of the case are those of cabin luggage to be placed on a table so that its light surface is at eye level of a seated person. It is designed to provide treatment during hospitalisation, outpatient care and during the transition from clinical care to everyday life in the context of home application.
High therapeutic effectiveness is made possible by the use of the unique Spectrasol Therapeutic light spectrum technology (protected by Patent No. 308363) with a high representation of wavelengths within the photosensitivity range of ipRGC cells, which act on the circadian system. At the same time, the spectral distribution is favourable to usersâ eyes by limiting harmful blue wavelengths below 450 nm and encompassing red wavelengths of around 670 nm.
Spectrasolâs unique spectral power distribution and key areas of emitted therapeutic light
Compared to other available devices, the device is equipped with an extra-large luminous area. This makes it possible to create a pleasant environment during the therapy, free of glare for the patient, with the possibility to engage in various activities during the application (reading, having breakfast, working on the computer, etc.).
The case is available in two versions â ON/OFF and with remote control. In the remote control version, the physician can pre-set the appropriate timing of the therapy and thus adapt the luminaire to the specific needs of the client. At the same time, online connection and data sharing can be enabled, so the attending physician is informed about the clientâs therapy progress.
Proven effectiveness
The National Institute of Mental Health of the Czech Republic has checked the effectiveness of phototherapy using the Spectrasol phototherapy case in the following areas:
- Affective experience and mood
- Sleep
- Circadian rhythms
- Monitoring patient cooperation
Technical data
| Dimensions of the device in its transport arrangement | 648x355x157 mm |
| Light area | 535×600 mm (3210 cm2) |
| Weight | 8 kg |
| Power input | max. 40 W |
| Melanopic daylight efficiency ratio (melanopic DER) | 0.934 |
| Photopic luminance* | 3000 lx |
| Equivalent melanopic daylight luminance* | 2750 lx |
| Correlated colour temperature (CCT) of the light | 5000 K |
| Colour rendering index (CRI) | >80 |
* at a recommended illumination distance of 50 cm
Therapy can only be carried out on the recommendation and according to the instructions of a specialist physician or therapist. Failure to observe this advice can cause adverse effects on the body.
The development and application methodology of the device were developed in cooperation with CTU UCEEB and the National Institute of Mental Health under project No. FW02020025 funded with the support of the Czech Technology Agency and the Ministry of Industry and Trade of the Czech Republic as part of the TREND programme
Photogallery
